378 related articles for article (PubMed ID: 32804279)
1. Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic.
Costamagna G; Abati E; Bresolin N; Comi GP; Corti S
J Neurol; 2021 May; 268(5):1580-1591. PubMed ID: 32804279
[TBL] [Abstract][Full Text] [Related]
2. Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey.
El-Hassar L; Amara A; Sanson B; Lacatus O; Amir Belhouchet A; Kroneman M; Claeys K; Plançon JP; Rodolico C; Primiano G; Trojsi F; Filosto M; Mongini TE; Bortolani S; Monforte M; Carraro E; Maggi L; Ricci F; Silani V; Orsucci D; Créange A; Péréon Y; Stojkovic T; van der Beek NAME; Toscano A; Pareyson D; Attarian S; Van den Bergh PYK; Remiche G; Hoeijmakers JGJ; Badrising U; Voermans NC; Kaindl AM; Schara-Schmidt U; Schoser B; Gazzerro E; Haberlová J; Voháňka S; Pál E; Molnar MJ; Leonardis L; Tournev IL; Osorio AN; Olivé M; Muelas N; Alonso-Perez J; Plá F; de Visser M; Siciliano G; Sacconi S
J Neuromuscul Dis; 2023; 10(2):173-184. PubMed ID: 36373291
[TBL] [Abstract][Full Text] [Related]
3. Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase.
Mauri E; Abati E; Musumeci O; Rodolico C; D'Angelo MG; Mirabella M; Lucchini M; Bello L; Pegoraro E; Maggi L; Manneschi L; Gemelli C; Grandis M; Zuppa A; Massucco S; Benedetti L; Caponnetto C; Schenone A; Prelle A; Previtali SC; Scarlato M; D'Amico A; Bertini E; Pennisi EM; De Giglio L; Pane M; Mercuri E; Mongini T; Ricci F; Berardinelli A; Astrea G; Lenzi S; Battini R; Ricci G; Torri F; Siciliano G; Santorelli FM; Ariatti A; Filosto M; Passamano L; Politano L; Scutifero M; Tonin P; Fossati B; Panicucci C; Bruno C; Ravaglia S; Monforte M; Tasca G; Ricci E; Petrucci A; Santoro L; Ruggiero L; Barp A; Albamonte E; Sansone V; Gagliardi D; Costamagna G; Govoni A; Magri F; Brusa R; Velardo D; Meneri M; Sciacco M; Corti S; Bresolin N; Moroni I; Messina S; Di Muzio A; Nigro V; Liguori R; Antonini G; Toscano A; Minetti C; Comi GP;
Acta Myol; 2020 Jun; 39(2):57-66. PubMed ID: 32904925
[TBL] [Abstract][Full Text] [Related]
4. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
Solé G; Salort-Campana E; Pereon Y; Stojkovic T; Wahbi K; Cintas P; Adams D; Laforet P; Tiffreau V; Desguerre I; Pisella LI; Molon A; Attarian S;
Rev Neurol (Paris); 2020 Jun; 176(6):507-515. PubMed ID: 32354651
[TBL] [Abstract][Full Text] [Related]
5. A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases.
Pisella LI; Fernandes S; Solé G; Stojkovic T; Tard C; Chanson JB; Bouhour F; Salort-Campana E; Beaudonnet G; Debergé L; Duval F; Grapperon AM; Masingue M; Nadaj-Pakleza A; Péréon Y; Audic F; Behin A; Friedman D; Magot A; Noury JB; Souvannanorath S; Wahbi K; Antoine JC; Bigaut K; Camdessanché JP; Cintas P; Debs R; Espil-Taris C; Kremer L; Kuntzer T; Laforêt P; Laugel V; Mallaret M; Michaud M; Nollet S; Svahn J; Vicart S; Villar-Quiles RN; Desguerre I; Adams D; Segovia-Kueny S; Merret G; Hammouda E; Molon A; Attarian S
Orphanet J Rare Dis; 2021 Oct; 16(1):450. PubMed ID: 34702344
[TBL] [Abstract][Full Text] [Related]
6. Telemedicine applied to neuromuscular disorders: focus on the COVID-19 pandemic era.
Giannotta M; Petrelli C; Pini A
Acta Myol; 2022 Mar; 41(1):30-36. PubMed ID: 35465343
[TBL] [Abstract][Full Text] [Related]
7. Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"?
Ricci G; Torri F; Bianchi F; Fontanelli L; Schirinzi E; Gualdani E; Francesconi P; Gagliardi D; Serra G; Mongini T; Siciliano G
Acta Myol; 2022 Mar; 41(1):24-29. PubMed ID: 35465339
[TBL] [Abstract][Full Text] [Related]
8. Teleneurology in a center for neuromuscular diseases during the COVID-19 pandemic.
Spiliopoulos KC; Kasdaglis N; Veltsista D; Lykouras D; Lagadinou M; Chroni E
Acta Neurol Belg; 2022 Jun; 122(3):721-724. PubMed ID: 34585321
[TBL] [Abstract][Full Text] [Related]
9. Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era.
Tseng YH; Chen TH
Front Neurol; 2021; 12():607790. PubMed ID: 33841296
[TBL] [Abstract][Full Text] [Related]
10. A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities.
Montes J; Eichinger KJ; Pasternak A; Yochai C; Krosschell KJ
Orphanet J Rare Dis; 2022 Jan; 17(1):5. PubMed ID: 34983609
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic.
Ricciardi D; Casagrande S; Iodice F; Orlando B; Trojsi F; Cirillo G; Clerico M; Bozzali M; Leocani L; Abbadessa G; Miele G; Tedeschi G; Bonavita S; Lavorgna L;
Neurol Sci; 2021 Dec; 42(12):4889-4892. PubMed ID: 34436726
[TBL] [Abstract][Full Text] [Related]
12. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
Živković SA; Gruener G; Narayanaswami P;
Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
[TBL] [Abstract][Full Text] [Related]
13. How to define and enhance diagnostic and assistance pathways in neuromuscular diseases during the COVID-19 pandemic: the concept of network.
Astrea G; Marinella G; Agosto C; Gagliardi D; Grandis M; Giuliano M; Politano L
Acta Myol; 2021 Dec; 40(4):172-176. PubMed ID: 35047757
[TBL] [Abstract][Full Text] [Related]
14. Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic.
Stratton AT; Roberts Iii RO; Kupfer O; Carry T; Parsons J; Apkon S
J Pediatr Rehabil Med; 2020; 13(3):405-414. PubMed ID: 33185615
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and neuromuscular disorders.
Guidon AC; Amato AA
Neurology; 2020 Jun; 94(22):959-969. PubMed ID: 32284362
[TBL] [Abstract][Full Text] [Related]
16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
17. Effect of the COVID-19 pandemic on patients with inherited neuromuscular disorders.
Moreno CAM; Camelo CG; Sampaio PHMA; Fonseca ATQSM; Estephan EP; Silva AMS; Pirola RN; Silva LHL; Lima KDF; Albuquerque MAV; Camelo Filho AE; Marques MVO; Yanagiura MT; Cavalcante WCP; Matsui Junior C; Isihi LMA; Mendonça RH; Pouza AFP; Carvalho MS; Reed UC; Zanoteli E
Arq Neuropsiquiatr; 2022 Jun; 80(6):563-569. PubMed ID: 35946707
[TBL] [Abstract][Full Text] [Related]
18. How to manage with telemedicine people with neuromuscular diseases?
Spina E; Trojsi F; Tozza S; Iovino A; Iodice R; Passaniti C; Abbadessa G; Bonavita S; Leocani L; Tedeschi G; Manganelli F; Lavorgna L;
Neurol Sci; 2021 Sep; 42(9):3553-3559. PubMed ID: 34173087
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry.
Pizzamiglio C; Pitceathly RDS; Lunn MP; Brady S; De Marchi F; Galan L; Heckmann JM; Horga A; Molnar MJ; Oliveira ASB; Pinto WBVR; Primiano G; Santos E; Schoser B; Servidei S; Sgobbi Souza PV; Venugopalan V; Hanna MG; Dimachkie MM; Machado PM;
Eur J Neurol; 2023 Feb; 30(2):399-412. PubMed ID: 36303290
[TBL] [Abstract][Full Text] [Related]
20. Impact of COVID-19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy.
Gagliardi D; Costamagna G; Abati E; Mauri E; Brusa R; Scudeller L; Andreoli L; Citterio G; Piccin E; Magri F; Meneri M; Velardo D; Sciacco M; Bresolin N; Corti S; Comi GP
Muscle Nerve; 2021 Oct; 64(4):474-482. PubMed ID: 34296433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
